About the Authors

Zul Premji

zpremji@muhas.ac.tz

Affiliation Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania

Rich E. Umeh

Affiliation College of Medicine, University of Nigeria, Enugu Campus, Enugu, Nigeria

Seth Owusu-Agyei

Affiliation Kintampo Health Research Center, Kintampo, Ghana

Fabian Esamai

Affiliation Department of Child Health and Paediatrics, School of Medicine, Moi University, Eldoret, Kenya

Emmanuel U. Ezedinachi

Affiliation Institute of Tropical Diseases Research and Prevention, University of Calabar Teaching Hospital, Calabar, Nigeria

Stephen Oguche

Affiliation Department of Paediatrics, Faculty of Medical Sciences, University of Jos/ Jos University Teaching Hospital (JUTH), Jos, Nigeria

Steffen Borrmann

Affiliations Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Kilifi, Kenya, University of Heidelberg School of Medicine, Heidelberg, Germany

Akintunde Sowunmi

Affiliation Malaria Research Laboratories, Institute for Advanced Medical Research and Training, College of Medicine, University of Ibadan, Ibadan, Nigeria

Stephan Duparc

Affiliation Medicines for Malaria Venture, Geneva, Switzerland, formerly at GlaxoSmithKline, Greenford, Middlesex, United Kingdom

Paula L. Kirby

Affiliation GlaxoSmithKline, Stockley Park West, Middlesex, United Kingdom

Allan Pamba

Affiliation GlaxoSmithKline, Greenford, Middlesex, United Kingdom

Lynda Kellam

Affiliation GlaxoSmithKline, Greenford, Middlesex, United Kingdom

Robert Guiguemdé

Affiliation Center Muraz, Bobo-Dioulasso, Burkina Faso

Brian Greenwood

Affiliation Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom

Stephen A. Ward

Affiliation Liverpool School of Tropical Medicine, Liverpool, United Kingdom

Peter A. Winstanley

Affiliation School of Clinical Sciences, University of Liverpool, Liverpool, United Kingdom

Competing Interests

The authors declare no conflict of interest other than P L Kirby, A Pamba and L Kellam who are employed by GlaxoSmithKline PLC and S Duparc who was employed by GlaxoSmithKline PLC at the time of the study and is now employed by the Medicines for Malaria Venture as stated in the affiliations.

Author Contributions

Conceived and designed the experiments: SD PLK AP BG SW PW. Performed the experiments: ZP REU SOA FE EUE SO SB AS RG. Analyzed the data: ZP REU SOA FE EUE SO SB AS SD AP LK RG BG SW PW. Wrote the paper: ZP AP LK. Critically reviewed the paper: REU SOA FE EUE SO SB AS SD PLK RG BG SW PW. Approved the final version of the paper: ZP REU SOA FE EUE SO SB AS SD PLK AP LK RG BG SW PW.